AI-generated illustration; not a photograph of the reported event.
- calendar_today November 7, 2026
Health Canada Issues Warning Over Unauthorized Peptide Products
Health Canada is alerting consumers against the use of unauthorized peptides, following laboratory tests that detected bacteria in certain injectable peptide products available for purchase online.
Prescription Drugs and Peptide Regulation in Canada
According to Health Canada, injectable peptides are typically regulated as prescription drugs within the country. These substances are intended for administration only under the supervision of a licensed healthcare professional to ensure safe use and prevent health risks.
Laboratory Testing Reveals Bacterial Contamination
The agency stated that during routine testing of seized products labeled as peptides, three distinct types of bacteria were found, all of which could potentially be harmful to humans. The contamination was identified in products acquired from Shanghai ERP Peptide Biotechnology Co. Ltd. (ERP Peptide) and two other online retailers distributing ERP Peptide's inventory.
Peptide Seizures and Affected Products
Health Canada reported confiscating more than 11,400 vials of these peptide drugs. The unauthorized products included Human Chorionic Gonadotropin, MOTS-C, NAD+, Retatrutide, Tesamorelin, and Tirzepatide. These peptide products had not been authorized for sale in Canada and bypassed the prescription drug regulatory process.
Health Risks Associated with Contaminated Peptides
The discovery of bacteria in these products underscores significant peptide safety concerns. Health officials warn that using contaminated or unapproved injectable substances poses serious health risks, prompting this public Health Canada warning and product recall. The agency emphasizes that consumers should never use injectable peptides obtained without a prescription or professional supervision, particularly those purchased through unauthorized online peptide sales.
Advice for Consumers and Future Actions
Given these findings, Health Canada advises the public to avoid the use of unauthorized peptide products, especially those linked to ERP Peptide. Consumers are urged to consult healthcare professionals regarding the safety and legitimacy of any injectable drugs, and to report any adverse effects or suspicious online products to the appropriate authorities. The agency continues to monitor and address peptide contamination and health risks from illicit drug sales.
Related coverage
Source: globalnews.ca.
